CHEMICAL-STRUCTURE AND ACTION OF ANTI-SCLEROTIC DRUGS (REVIEW OF LITERATURE)

[51] RYZHENKOV V E, 1978, Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya, P50

[52] RYZHENKOV V E, 1977, Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya, P79

[53] Ryzhenkov V. E., 1979, FARMAKOL TOKSIKOL, p632

[54] RYZHENKOV VE, 1976, B EKSP BIOL MED, P558

[55] Schacht E, 1977, Top Curr Chem, V72, P99

[56] SHVARTS GY, 1977, KHIM FARM ZH, P139

[57] PHARMACOLOGICAL PROFILE OF BR-931, A NEW HYPOLIPIDEMIC AGENT THAT INCREASES HIGH-DENSITY LIPOPROTEINS [J]. ATHEROSCLEROSIS, 1978, 30 (01) : 45 - 56

[58] SIRTORI CR, 1978, ATHEROSCLER REV, V3, P183

[59] SIRTORY A, 1976, LIPIDS, V7, P296

[60] SMITH J, 1976, JAMA, V236, P1992

[51] RYZHENKOV V E, 1978, Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya, P50

[52] RYZHENKOV V E, 1977, Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya, P79

[53] Ryzhenkov V. E., 1979, FARMAKOL TOKSIKOL, p632

[54] RYZHENKOV VE, 1976, B EKSP BIOL MED, P558

[55] Schacht E, 1977, Top Curr Chem, V72, P99

[56] SHVARTS GY, 1977, KHIM FARM ZH, P139

[57] PHARMACOLOGICAL PROFILE OF BR-931, A NEW HYPOLIPIDEMIC AGENT THAT INCREASES HIGH-DENSITY LIPOPROTEINS [J]. ATHEROSCLEROSIS, 1978, 30 (01) : 45 - 56

[58] SIRTORI CR, 1978, ATHEROSCLER REV, V3, P183

[59] SIRTORY A, 1976, LIPIDS, V7, P296

[60] SMITH J, 1976, JAMA, V236, P1992